May contain cereals containing gluten, soy, milk, eggs , and derived products
Un hallazgo epidemiolgico que impulsa nuevas preguntas Los llamados agonistas del receptor de GLP-1, entre ellos semaglutida (Ozempic, Wegovy), liraglutida y dulaglutida, se desarrollaron originalmente para mejorar el control glucmico en personas con diabetes tipo 2
Regulators have documented counterfeit products with falsified pharmacy labeling, and clinicians have raised specific concerns about the variability of the compounded market
It is also believed to stimulate dermatan sulfate, chondroitin sulfate, and decorin, and acts to attract immune and endothelial cells to sites of injury
PMID 17606868